Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature.

antitoxin botulinum toxin botulism iatrogenic

Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 Mar 2024
Historique:
received: 10 07 2023
accepted: 02 09 2023
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: epublish

Résumé

Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application. In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application. The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended. Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.

Identifiants

pubmed: 38635607
doi: 10.3855/jidc.18868
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-487

Informations de copyright

Copyright (c) 2024 Fatma Eser, İmran Hasanoğlu, Bircan Kayaaslan, Ayşe Kaya Kalem, Şule Bilen, Gürdal Orhan, Rahmet Güner.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Fatma Eser (F)

Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.

İmran Hasanoğlu (İ)

Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.

Bircan Kayaaslan (B)

Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.

Ayşe Kaya Kalem (A)

Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.

Şule Bilen (Ş)

University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey.

Gürdal Orhan (G)

University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey.

Rahmet Güner (R)

Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey.

Classifications MeSH